SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...
Myriad Genetics , Inc. (NASDAQ:MYGN) stock has reached a new 52-week low, touching down at $12.16, as the company faces a challenging market environment. According to InvestingPro data, technical ...
Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction.
A former Colorado Bureau of Investigation DNA scientist faces 102 criminal charges after authorities said she cut corners and didn’t follow standard testing protocols in hundreds of criminal cases ...
The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...
This test is for anyone who struggles with resilience or wants to learn more about their approach to life. This test is designed for adults and is not intended to be diagnostic.